1
/
of
1
Elabscience
SKU:PKSQ050120
Recombinant Rhesus Macaque Angiotensin-Converting Enzyme 2/ACE-2 (C-Fc)
Recombinant Rhesus Macaque Angiotensin-Converting Enzyme 2/ACE-2 (C-Fc)
Regular price
$330.00 USD
Regular price
Sale price
$330.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Rhesus Macaque Angiotensin-Converting Enzyme 2/ACE-2 (C-Fc), a cutting-edge product meticulously designed to cater to the needs of scientific research and pharmaceutical development. This innovative offering showcases a fusion protein comprising the Rhesus Macaque Angiotensin-Converting Enzyme 2 (ACE-2) and the constant region of human IgG1 (C-Fc), ensuring utmost reliability and efficacy in experimental applications.
Crafted with utmost precision, this recombinant protein exhibits exceptional purity and bioactivity, making it an indispensable tool for investigating the intricate mechanisms underlying ACE-2-mediated cellular processes. Its recombinant nature guarantees consistency and reproducibility, enabling researchers to obtain accurate and reliable results in their studies.
The fusion of Rhesus Macaque ACE-2 with the C-Fc region of human IgG1 not only enhances stability but also facilitates ease of purification, ensuring a streamlined workflow for researchers. This fusion protein's high affinity for the SARS-CoV-2 spike protein further positions it as an invaluable asset in the development of potential therapeutic interventions against COVID-19.
With its comprehensive range of applications, the Recombinant Rhesus Macaque Angiotensin-Converting Enzyme 2/ACE-2 (C-Fc) serves as an indispensable tool for various research areas, including viral pathogenesis, drug discovery, and vaccine development. Its versatility extends to functional assays, protein-protein interaction studies, and receptor-ligand binding investigations, empowering scientists to unravel the complexities of ACE-2 biology.
Rest assured, this product adheres to the highest quality standards, meticulously manufactured under stringent conditions to ensure optimal performance and reliability. Each batch undergoes rigorous quality control measures, guaranteeing consistent and reproducible results, thereby instilling confidence in researchers' endeavors.
In summary, the Recombinant Rhesus Macaque Angiotensin-Converting Enzyme 2/ACE-2 (C-Fc) stands as an exceptional offering, poised to revolutionize scientific research and pharmaceutical development. Its fusion protein design, coupled with its purity, bioactivity, and versatility, renders it an indispensable tool for unraveling the intricacies of ACE-2 biology and advancing our understanding of various diseases, including COVID-19.
Crafted with utmost precision, this recombinant protein exhibits exceptional purity and bioactivity, making it an indispensable tool for investigating the intricate mechanisms underlying ACE-2-mediated cellular processes. Its recombinant nature guarantees consistency and reproducibility, enabling researchers to obtain accurate and reliable results in their studies.
The fusion of Rhesus Macaque ACE-2 with the C-Fc region of human IgG1 not only enhances stability but also facilitates ease of purification, ensuring a streamlined workflow for researchers. This fusion protein's high affinity for the SARS-CoV-2 spike protein further positions it as an invaluable asset in the development of potential therapeutic interventions against COVID-19.
With its comprehensive range of applications, the Recombinant Rhesus Macaque Angiotensin-Converting Enzyme 2/ACE-2 (C-Fc) serves as an indispensable tool for various research areas, including viral pathogenesis, drug discovery, and vaccine development. Its versatility extends to functional assays, protein-protein interaction studies, and receptor-ligand binding investigations, empowering scientists to unravel the complexities of ACE-2 biology.
Rest assured, this product adheres to the highest quality standards, meticulously manufactured under stringent conditions to ensure optimal performance and reliability. Each batch undergoes rigorous quality control measures, guaranteeing consistent and reproducible results, thereby instilling confidence in researchers' endeavors.
In summary, the Recombinant Rhesus Macaque Angiotensin-Converting Enzyme 2/ACE-2 (C-Fc) stands as an exceptional offering, poised to revolutionize scientific research and pharmaceutical development. Its fusion protein design, coupled with its purity, bioactivity, and versatility, renders it an indispensable tool for unraveling the intricacies of ACE-2 biology and advancing our understanding of various diseases, including COVID-19.
Share
